Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Privia Health Group ( (PRVA) ) has shared an update.
On August 28, 2025, Privia Health Group announced its Accountable Care Organizations (ACOs) achieved $233.1 million in shared savings through the Medicare Shared Savings Program for 2024, marking a 32% increase from the previous year. This performance underscores the effectiveness of Privia’s physician-led approach and data-driven tools, benefiting nearly 195,000 Medicare beneficiaries. The company also increased its Adjusted EBITDA guidance for 2025 to $113-$116 million, reflecting its strong operational performance and strategic positioning in the healthcare industry.
The most recent analyst rating on (PRVA) stock is a Hold with a $21.00 price target. To see the full list of analyst forecasts on Privia Health Group stock, see the PRVA Stock Forecast page.
Spark’s Take on PRVA Stock
According to Spark, TipRanks’ AI Analyst, PRVA is a Outperform.
Privia Health Group’s strong financial performance and positive earnings call are the most significant factors driving the score. However, the high P/E ratio suggests overvaluation, and technical indicators point to potential short-term volatility.
To see Spark’s full report on PRVA stock, click here.
More about Privia Health Group
Privia Health is a leading physician enablement company in the United States, operating in 15 states and the District of Columbia. It builds provider networks with primary-care centric medical groups and offers a suite of technology and service solutions. The company collaborates with medical groups, health plans, and health systems to optimize practice locations, improve patient experiences, and reward physicians for delivering high-value care.
Average Trading Volume: 955,396
Technical Sentiment Signal: Hold
Current Market Cap: $2.68B
For an in-depth examination of PRVA stock, go to TipRanks’ Overview page.